JP2016518424A5 - - Google Patents

Download PDF

Info

Publication number
JP2016518424A5
JP2016518424A5 JP2016513342A JP2016513342A JP2016518424A5 JP 2016518424 A5 JP2016518424 A5 JP 2016518424A5 JP 2016513342 A JP2016513342 A JP 2016513342A JP 2016513342 A JP2016513342 A JP 2016513342A JP 2016518424 A5 JP2016518424 A5 JP 2016518424A5
Authority
JP
Japan
Prior art keywords
composition
methylpropanol
amino
polyacrylic acid
herpes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2016513342A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016518424A (ja
Filing date
Publication date
Priority claimed from EP13167597.7A external-priority patent/EP2803354B1/de
Application filed filed Critical
Publication of JP2016518424A publication Critical patent/JP2016518424A/ja
Publication of JP2016518424A5 publication Critical patent/JP2016518424A5/ja
Pending legal-status Critical Current

Links

JP2016513342A 2013-05-14 2014-05-14 ヘルペス処置のための薬剤と方法 Pending JP2016518424A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP13167597.7A EP2803354B1 (de) 2013-05-14 2013-05-14 Kombination aus Polyacrylsäure und 2-Amino-2-methylpropanol zur Verwendung in der Behandlung von Herpesinfektionen
EP13167597.7 2013-05-14
PCT/EP2014/059813 WO2014184223A1 (de) 2013-05-14 2014-05-14 Mittel und verfahren zur behandlung von herpes

Publications (2)

Publication Number Publication Date
JP2016518424A JP2016518424A (ja) 2016-06-23
JP2016518424A5 true JP2016518424A5 (cg-RX-API-DMAC10.html) 2017-04-27

Family

ID=48366229

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016513342A Pending JP2016518424A (ja) 2013-05-14 2014-05-14 ヘルペス処置のための薬剤と方法

Country Status (7)

Country Link
US (1) US20160166603A1 (cg-RX-API-DMAC10.html)
EP (1) EP2803354B1 (cg-RX-API-DMAC10.html)
JP (1) JP2016518424A (cg-RX-API-DMAC10.html)
AU (1) AU2014267349A1 (cg-RX-API-DMAC10.html)
BR (1) BR112015028334A2 (cg-RX-API-DMAC10.html)
ES (1) ES2538335T3 (cg-RX-API-DMAC10.html)
WO (1) WO2014184223A1 (cg-RX-API-DMAC10.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017212422A1 (en) * 2016-06-08 2017-12-14 Novartis Consumer Health Sa Topical compositions comprising carbomer for the treatment and prevention of viral infections and allergic conditions
US20210330700A1 (en) * 2020-04-23 2021-10-28 Johnson & Johnson Consumer Inc. Methods and compositions for inhibiting influenza viruses using low molecular weight hydrophobically modified polymers and polyalkylene glycols
DE102025101480A1 (de) 2025-01-16 2026-07-16 Pigmentsolution GmbH Konservierungszusammensetzung
DE202026100173U1 (de) 2025-01-16 2026-05-28 Pigmentsolution GmbH Rohr-im-Rohr-Homogenisierer
EP4778390A3 (de) 2025-01-16 2026-08-12 Pigmentsolution GmbH Konservierungszusammensetzung

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2174242A (en) 1937-08-13 1939-09-26 Purdue Research Foundation Aminoglycols
JPS6251617A (ja) * 1985-08-30 1987-03-06 Wako Pure Chem Ind Ltd ビダラビンゲル軟膏
JPS62263111A (ja) * 1986-05-09 1987-11-16 Shiseido Co Ltd 粘性組成物
US5075104A (en) * 1989-03-31 1991-12-24 Alcon Laboratories, Inc. Ophthalmic carboxy vinyl polymer gel for dry eye syndrome
US5622690A (en) * 1990-04-05 1997-04-22 Nurture, Inc. Seed-derived proteinaceous compositions for reduction of sunburn cell formation
JPH08143460A (ja) * 1994-11-17 1996-06-04 Haruhito Miyata 水虫類の治療方法及び用材
JPH11511180A (ja) * 1996-06-12 1999-09-28 ストア ソシエテ アノニマ 化粧品のための物理的殺菌用ゲル
US7442369B1 (en) * 2000-08-09 2008-10-28 Mcneil Ab Compositions of minoxidil
JPWO2004069261A1 (ja) * 2003-02-03 2006-05-25 アリジェン株式会社 抗ヘルペスウイルス外用製剤の製造方法
JP2005263695A (ja) * 2004-03-18 2005-09-29 Suiko Giken Kk 水虫治療薬
US20060229364A1 (en) * 2005-03-10 2006-10-12 3M Innovative Properties Company Antiviral compositions and methods of use
US8267927B2 (en) * 2007-01-24 2012-09-18 Koninklijke Philips Electronics N.V. Advanced ablation planning
WO2010127033A1 (en) * 2009-04-28 2010-11-04 Alltranz Inc. Formulations of cannabidiol and methods of using the same
IT1395137B1 (it) * 2009-08-05 2012-09-05 Spider Biotech S R L Nuovi peptidi antipatogeni
JP2011030981A (ja) * 2009-08-06 2011-02-17 Dainippon Printing Co Ltd 皮膚貼付用組成物および皮膚貼付用材
WO2012004669A1 (en) * 2010-07-08 2012-01-12 Devirex Ag Polyethylene glycol compositions for controlling relapse of herpes labialis, herpes genitalis, and herpes zoster
US20130072575A1 (en) * 2011-09-19 2013-03-21 Johnson & Johnson Consumer Companies, Inc. Method and Composition for Treating Pain

Similar Documents

Publication Publication Date Title
SA519402405B1 (ar) مركبات مثبط فيروس نقص المناعة البشري
PH12018550201A1 (en) Hepatitis b antiviral agents
EA201891876A1 (ru) Тетрациклические пиридоновые соединения в качестве противовирусных средств
PH12019502052A1 (en) Hepatitis b virus surface antigen inhibitor
MX2022009352A (es) Sal de hemisulfato de nucleotido para el tratamiento del virus de hepatitis c.
CL2017000379A1 (es) Compuestos de pirrolopirimidina usados como agonistas del receptor de tipo toll. 7 (tlr7)
PE20191043A1 (es) Composicion farmaceutica
WO2012065963A3 (en) Antiviral condensed heterocyclic compounds
HK1209638A1 (en) Pharmaceutical compositions
PH12015502539A1 (en) Cenicriviroc compositions and methods of making and using the same
CO6761348A2 (es) Compuestos antivirales
JO3430B1 (ar) مشتقات حمض أميني جديدة، عملية لتحضيرها وتركيبات صيدلية تحتوي عليها
BR112014019584A8 (pt) Composto da fórmula (i), sua forma tautomérica, seu isômero, ou seu sal farmaceuticamente aceitável, composição farmacêutica, método de inibição da replicação de um vírus contendo rna, método de tratamento ou prevenção de infecção causada por um vírus contendo rna, e, método de tratamento de infecção por hepatite c
EA201890196A1 (ru) Композиция для устранения заложенности носа, обладающая противовирусным действием
CN108026053A8 (zh) 作为mIDH1抑制剂的稠合的咪唑类化合物
PH12016500985A1 (en) Use of benzimidazole-proline derivatives
BR112012027803A2 (pt) compostos de pirazol como inibidores de jak
EA201591397A1 (ru) Хиноксалиноны и дигидрохиноксалиноны как антивирусные средства против респираторно-синцитиального вируса
CL2018003390A1 (es) Beta-horquilla peptidomimética con actividad inhibidora de elastasa y formas de dosificación en aerosol de la misma.
EA201492091A1 (ru) Фармацевтические композиции для местного применения, содержащие тербинафид и мочевину
PE20191044A1 (es) Composicion farmaceutica
WO2016195522A3 (en) Antiviral composition
WO2017161133A8 (en) N-hydroxyisoquinolinedione inhibitors of hbv replication
JP2011157392A5 (cg-RX-API-DMAC10.html)
MX388699B (es) Formas cristalinas de cabotegravir de sodio